Distinct remission immune architectures under rituximab and azathioprine in AQP4-IgG-positive neuromyelitis optica spectrum disorder. Shin W, Yoon B, Kim H J, Seo D, Jang I, Ryu J, Choi L, Kim J H, Kim H, Lim Y-M, et al. Front Immunol. 2026; 17:1834992. PMID: 42183204. Abstract CommentRecommendBookmarkWatch